Loading provider…
Loading provider…
Nuclear Medicine Physician in Ann Arbor, MI
NPI: 1013009075Primary Practice Location
UNIVERSITY OF MICHIGAN HEALTH SYSTEM
1540 E Hospital Dr, Ann Arbor, MI
Primary Employer
Regents of the University of Michigan
michiganmedicine.org
HQ Phone
Get MD Morand's Phone Numberphone_androidMobile
Get MD Morand's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
MI State Medical License
1992 - 2026

American Board of Nuclear Medicine
Nuclear Medicine
Medizinische Fakultät Universität zu Köln
Medical School
Until 1984
University of Michigan
Residency • Nuclear Medicine
—
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 77080Bone density measurement using dedicated X-ray machine | 173 | 173 |
| 2 | 78815Nuclear medicine study with CT imaging skull base to mid-thigh | 121 | 121 |
| 3 | 78306Bone and/or joint imaging, whole body | 69 | 73 |
| 4 | 78816Nuclear medicine study with CT imaging whole body | 30 | 30 |
| 5 | 78195Imaging of lymphatic tissue and lymph node | 21 | 21 |
Authors: Mohammad Arabi, Rolando Alvarez, Kirk Frey, Richard Brown, Ben Dwamena
Journal: J Comput Assist Tomogr
Concurrent Temozolomide and Dose-Escalated Intensity-Modulated Radiation Therapy in Newly Diagnosed Glioblastoma
Authors: Christina Tsien, Doris Brown, Daniel P. Normolle, Matthew J. Schipper, Morand Piert, Larry Junck, Jason Heth, Diana Gomez-Hassan, Randall K. Ten Haken, Thomas L. Chenevert, Yue Cao, Theodore Lawrence
Publication Date: 2012-01
Authors: Picchio, Maria, Beck, Roswitha, Haubner, Roland, Seidl, Stefan, Machulla, Hans-Jürgen, Johnson, Timothy D, Wester, Hans-Jürgen, Reischl, Gerald, Schwaiger, Markus, Piert, Morand
Journal: J Nucl Med
Publication Date: 2008-03-14
Lead Sponsor: University of Michigan Rogel Cancer Center
Intervention / Treatment: DRUG: 68Ga-PSMA
Lead Sponsor: Endocyte
Intervention / Treatment: DRUG: 177Lu-PSMA-617, OTHER: Best supportive/best standard of care
Lead Sponsor: University of Michigan
Intervention / Treatment: DRUG: 68Ga-PSMA